Combating Alzheimer’s Disease: An Exploration of Resveratrol Treatment and Early Disease Detection Using Drosophila melanogaster and Machine Learning
ISEF · 2021 Translational Medical Science
Overview
Alzheimer's Disease (AD) is a neurodegenerative disease that destroys memory and thinking. This study focused on two critical gaps in AD research: novel treatment identification and early disease detection. The first phase of this study addressed the need for novel AD treatments by investigating one potential treatment, resveratrol. A Presenilin (Psn) Drosophila melanogaster model of AD was employed to test the effect of resveratrol on short-term memory through olfactory conditioning. Resveratrol was found to significantly improve the short-term memory of Psn flies, but only when it was administered immediately upon the birth of the flies. This demonstrated resveratrol's potential as an AD treatment, but also indicated that early administration is crucial to maximizing the effectiveness of the treatment. Notably, past literature has demonstrated that this is not unique to resveratrol. The second phase of this study strove to address the need for early disease detection — a crucial step in allowing for early treatment administration. Specifically, a machine learning classifier was developed to predict AD diagnoses based on patient MRI data. Unlike past machine learning models, this classifier was based on multiple cluster dense convolutional neural networks (DenseNets), a novel structure of convolutional neural networks that connects all layers in a feed-foward fashion, thus reusing features from all previous layers and achieving better performance. When the classifier was trained and tested using longitudinal MRI data from AD, mild cognitive impairment (MCI), and healthy patients, an overall accuracy rate of over 95% was achieved. Ultimately, the two facets of this study unite to provide valuable insights for discovering and maximizing AD treatments.
Competition history
- ISEF 2021
Resources
Related projects
ISEF · 2020
Combating Familial Alzheimer's Disease: A Study of Resveratrol's Effects on a Presenilin Model of Drosophila melanogaster
ISEF · 2020
Developing a Pre-Risk Assessment Incorporating Machine-Learning and Biomarkers to Diagnose Alzheimer's Disease
CWSF · 2026
Window to the Mind: A Multi-Stage Computational Pipeline for Early Alzheimer's Intervention
ISEF · 2015
Alzheimer’s and Drosophila: Effect of Age on Efficacy of Treatment in a Model System
ISEF · 2026
The Impacts of Resveratrol and Escherichia coli Dietary Restriction on the Behavioral and Pathological Aspects of Alzheimer's Disease Using Caenorhabditis elegans as a Model
ISEF · 2018
Assessing Progression of Alzheimer’s Disease: Predicting Cognitive Impairments and Amyloid Deposition Through PET and MRI
ISEF · 2024
Identification of Novel Target Genes and ML-Based Drug Repurposing and Discovery for Alzheimer’s Disease in the Presence of Metabolic Comorbidities
ISEF · 2024
Novel Drug Discovery Methodology Using Machine Learning for Gene Expression-Based Virtual Screening Predicts Novel Compounds To Reverse Alzheimer's Disease With Applications to Cancer and Longevity by Inhibiting CtBP2 Expression
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair